Accelerating clinical research as study complexity grows

Clinical Trials & Research

How early planning and a unified data platform can cut trial timelines and costs

Add bookmark




We respect your privacy, by clicking “Download Your Copy” you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts,
online learning opportunities and agree to our User Agreement. You have the right to object . In addition, you agree to having your details
passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. For
further information on how we process and monitor your personal data click
here.
You can unsubscribe at any time.

The complexity of clinical trials has grown dramatically in recent years as the number of procedures performed per patient in Phase III trials increases. The jump in the number of procedures has led to a rapid growth in the data created by and required for developing modern therapies.

Combined with longstanding patient recruitment challenges, traditional clinical trial approaches have become overwhelmed, as complex trials take longer to run. The cost of longer therapy development timelines can prove too high for both patients and companies working in the field.

By using a flexible, scalable unified interface, powerful analytics and user-friendly technology to reduce total study timelines and the number of protocol amendments, pharma companies can cut trial timelines and reduce costs.

This report addresses pain points such as patient enrollment, site recruitment and retention, and data clean-up, and explains why solving the IT and platform integration problems can address compliance and regulatory concerns, as well as data and performance issues that could further delay trials.

Download this white paper from Medidata to learn:

  • What the ideal data platform for accelerating clinical trials looks like.
  • Why a flexible and unified trial platform can help relieve major clinical trial pain points.
  • How to address complex and costly patient enrollment trial challenges through an integrated feasibility process.

We respect your privacy, by clicking “Download Your Copy” you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts,
online learning opportunities and agree to our User Agreement. You have the right to object . In addition, you agree to having your details
passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. For
further information on how we process and monitor your personal data click
here.
You can unsubscribe at any time.

Sponsored By:

Medidata Solutions Worldwide

Products You May Like

Articles You May Like

Covid: Coronavirus cases in England up 60% in a week
Covid-19: UK volunteers could be given virus to test vaccine
HNC Products Inc. – 607359 – 09/10/2020
Medtronic enrols first subjects in insertable cardiac monitor trial
Psychological intimate partner violence, insecure attachment, and parental psychological control from adolescence to emerging adulthood – Choe SY, Lee JO, Read SJ.

Leave a Reply